224 related articles for article (PubMed ID: 34127622)
1. At a crossroads: coronavirus disease 2019 recovery and the risk of pulmonary vascular disease.
Cascino TM; Desai AA; Kanthi Y
Curr Opin Pulm Med; 2021 Sep; 27(5):342-349. PubMed ID: 34127622
[TBL] [Abstract][Full Text] [Related]
2. One year of COVID-19 pandemic: what we Radiologists have learned about imaging.
Gross A; Albrecht T
Rofo; 2022 Feb; 194(2):141-151. PubMed ID: 34649291
[TBL] [Abstract][Full Text] [Related]
3. From acute SARS-CoV-2 infection to pulmonary hypertension.
Eroume À Egom E; Shiwani HA; Nouthe B
Front Physiol; 2022; 13():1023758. PubMed ID: 36601347
[TBL] [Abstract][Full Text] [Related]
4. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective.
Halawa S; Pullamsetti SS; Bangham CRM; Stenmark KR; Dorfmüller P; Frid MG; Butrous G; Morrell NW; de Jesus Perez VA; Stuart DI; O'Gallagher K; Shah AM; Aguib Y; Yacoub MH
Nat Rev Cardiol; 2022 May; 19(5):314-331. PubMed ID: 34873286
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Hypertension and COVID-19.
Castiglione L; Droppa M
Hamostaseologie; 2022 Aug; 42(4):230-238. PubMed ID: 34933375
[TBL] [Abstract][Full Text] [Related]
6. Long-term side effects and lingering symptoms post COVID-19 recovery.
Zarei M; Bose D; Nouri-Vaskeh M; Tajiknia V; Zand R; Ghasemi M
Rev Med Virol; 2022 May; 32(3):e2289. PubMed ID: 34499784
[TBL] [Abstract][Full Text] [Related]
7. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
8. COVID-19: from an acute to chronic disease? Potential long-term health consequences.
Higgins V; Sohaei D; Diamandis EP; Prassas I
Crit Rev Clin Lab Sci; 2021 Aug; 58(5):297-310. PubMed ID: 33347790
[TBL] [Abstract][Full Text] [Related]
9. Thromboembolic Complications in Severe COVID-19: Current Antithrombotic Strategies and Future Perspectives.
Rodriguez JJ; Munoz OC; Porres-Aguilar M; Mukherjee D
Cardiovasc Hematol Disord Drug Targets; 2021; 21(1):23-29. PubMed ID: 33719953
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulants for people hospitalised with COVID-19.
Flumignan RL; Civile VT; Tinôco JDS; Pascoal PI; Areias LL; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013739. PubMed ID: 35244208
[TBL] [Abstract][Full Text] [Related]
11. Long COVID.
Guziejko K; Tałałaj J; Czupryna P; Moniuszko-Malinowska A
Przegl Epidemiol; 2022; 76(3):287-295. PubMed ID: 36520039
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of coronavirus infectious disease 2019-related neurologic diseases.
Klein RS
Curr Opin Neurol; 2022 Jun; 35(3):392-398. PubMed ID: 35283461
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 and cardiovascular disease: manifestations, pathophysiology, vaccination, and long-term implication.
Abdel Moneim A; Radwan MA; Yousef AI
Curr Med Res Opin; 2022 Jul; 38(7):1071-1079. PubMed ID: 35575011
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
15. COVID-19: Pulmonary and Extra Pulmonary Manifestations.
Elrobaa IH; New KJ
Front Public Health; 2021; 9():711616. PubMed ID: 34650947
[No Abstract] [Full Text] [Related]
16. The Outcome of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the COVID-19 Pandemic.
Serati A; Keshmiri MS; Shafaghi S; Mohammad MM; Kashani BS; Naghashzadeh F; Mohamadifar A; Shafaghi M; Noorali S; Hajimoradi M; Astani B; Aghdasi S; Riahi M; Alavi S; Malek R; Movahed MR
Crit Pathw Cardiol; 2023 Jun; 22(2):60-64. PubMed ID: 37220659
[TBL] [Abstract][Full Text] [Related]
17. [ANMCO Position paper: Pulmonary circulation diseases and COVID-19].
Picariello C; Caravita S; Vatrano M; Enea I; Roncon L; De Tommasi E; Imbalzano E; Garascia A; Manes MT; Misuraca L; Urbinati S; Colivicchi F; Gulizia MM; Gabrielli D;
G Ital Cardiol (Rome); 2020 Aug; 21(8):575-583. PubMed ID: 32686781
[TBL] [Abstract][Full Text] [Related]
18. Return-to-work, disabilities and occupational health in the age of COVID-19.
Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
[TBL] [Abstract][Full Text] [Related]
19. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study.
Montani D; Certain MC; Weatherald J; Jaïs X; Bulifon S; Noel-Savina E; Nieves A; Renard S; Traclet J; Bouvaist H; Riou M; de Groote P; Moceri P; Bertoletti L; Favrolt N; Guillaumot A; Jutant EM; Beurnier A; Boucly A; Ebstein N; Jevnikar M; Pichon J; Keddache S; Preda M; Roche A; Solinas S; Seferian A; Reynaud-Gaubert M; Cottin V; Savale L; Humbert M; Sitbon O;
Am J Respir Crit Care Med; 2022 Sep; 206(5):573-583. PubMed ID: 35549842
[No Abstract] [Full Text] [Related]
[Next] [New Search]
